Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 CAD | -5.56% | -5.56% | -96.37% |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 12.24 | 4.982 | 1.978 | 4.435 | 6.283 | 11.56 |
Enterprise Value (EV) 1 | 8.838 | 2.374 | 2.792 | 0.2892 | -4.315 | -5.086 |
P/E ratio | 2.68 x | -1 x | -0.27 x | -0.98 x | 2.74 x | 3.97 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.72 x | 0.64 x | 0.34 x | 0.62 x | 1.82 x | 2.69 x |
EV / Revenue | 1.96 x | 0.3 x | 0.48 x | 0.04 x | -1.25 x | -1.18 x |
EV / EBITDA | -5.81 x | -2.39 x | -1.39 x | -0.3 x | 2.05 x | 2.1 x |
EV / FCF | -0.81 x | 16.8 x | 1.45 x | 0.12 x | -7.06 x | 3.45 x |
FCF Yield | -124% | 5.94% | 69% | 865% | -14.2% | 29% |
Price to Book | 0.43 x | 0.21 x | 0.12 x | 0.37 x | 0.44 x | 0.67 x |
Nbr of stocks (in thousands) | 7,242 | 7,327 | 7,327 | 7,392 | 7,392 | 7,653 |
Reference price 2 | 1.690 | 0.6800 | 0.2700 | 0.6000 | 0.8500 | 1.510 |
Announcement Date | 05/10/18 | 11/10/19 | 21/10/20 | 25/10/21 | 25/10/22 | 26/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 4.506 | 7.813 | 5.788 | 7.196 | 3.444 | 4.3 |
EBITDA 1 | -1.52 | -0.9928 | -2.014 | -0.9608 | -2.1 | -2.417 |
EBIT 1 | -1.551 | -1.055 | -2.113 | -1.153 | -2.208 | -2.513 |
Operating Margin | -34.42% | -13.51% | -36.5% | -16.03% | -64.13% | -58.45% |
Earnings before Tax (EBT) 1 | 6.546 | -6.748 | -10.01 | -5.712 | 2.983 | 4.03 |
Net income 1 | 4.73 | -4.953 | -7.354 | -4.482 | 2.318 | 2.917 |
Net margin | 104.96% | -63.39% | -127.07% | -62.29% | 67.3% | 67.84% |
EPS 2 | 0.6300 | -0.6808 | -1.004 | -0.6110 | 0.3100 | 0.3800 |
Free Cash Flow 1 | -10.95 | 0.141 | 1.927 | 2.502 | 0.6115 | -1.476 |
FCF margin | -243.02% | 1.81% | 33.29% | 34.78% | 17.76% | -34.32% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | 26.38% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 05/10/18 | 11/10/19 | 21/10/20 | 25/10/21 | 25/10/22 | 26/09/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 0.81 | - | - | - |
Net Cash position 1 | 3.4 | 2.61 | - | 4.15 | 10.6 | 16.6 |
Leverage (Debt/EBITDA) | - | - | -0.4042 x | - | - | - |
Free Cash Flow 1 | -11 | 0.14 | 1.93 | 2.5 | 0.61 | -1.48 |
ROE (net income / shareholders' equity) | 18% | -18.8% | -36.4% | -31.5% | 17.6% | 18.4% |
ROA (Net income/ Total Assets) | -2.74% | -1.85% | -5% | -4.28% | -9.43% | -9.02% |
Assets 1 | -172.9 | 267.1 | 147 | 104.7 | -24.59 | -32.33 |
Book Value Per Share 2 | 3.970 | 3.280 | 2.240 | 1.630 | 1.940 | 2.270 |
Cash Flow per Share 2 | 0.8300 | 0.7000 | 0.2900 | 0.5700 | 1.440 | 2.170 |
Capex 1 | 1.14 | 1.7 | 0.27 | 0.02 | 0.01 | 0 |
Capex / Sales | 25.25% | 21.76% | 4.65% | 0.24% | 0.37% | 0.08% |
Announcement Date | 05/10/18 | 11/10/19 | 21/10/20 | 25/10/21 | 25/10/22 | 26/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-96.37% | 473K | |
+17.55% | 1.03B | |
-.--% | 780M | |
-37.75% | 556M | |
+6.57% | 375M | |
-21.29% | 337M | |
+1.45% | 307M | |
+2.78% | 245M | |
-36.01% | 257M | |
-38.50% | 226M |
- Stock Market
- Equities
- IGP Stock
- Financials Imperial Ginseng Products Ltd.